New wipe could stop armpit sweat in its tracks

NCT ID NCT02129660

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested two different medicated wipes (glycopyrrolate and glycopyrronium) against a placebo wipe for people with excessive underarm sweating. 105 adults used the wipes once daily for 4 weeks, then stopped for 2 weeks. Researchers measured sweat production and how much sweating affected daily life to see if the wipes helped.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
glycopyrrolate and glycopyrronium topical wipes
What this could lead to
If successful, this could lead to a new prescription wipe that reduces excessive underarm sweating with daily use.
What could go wrong
This is an early Phase 2 trial with only 105 people, so results may not apply to everyone. The treatment is for symptom control, not a cure, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERHIDROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • California Dermatology & Clinical Research Institute

    Encinitas, California, 92024, United States

  • Center For Dermatology Clinical Research

    Fremont, California, 94538, United States

  • DermResearch, Inc

    Austin, Texas, 78759, United States

  • Dermatology Associates

    Seattle, Washington, 98101, United States

  • Dermatology Research Center, Inc.

    Salt Lake City, Utah, 84117, United States

  • Haber Dermatology and Cosmetic Surgery

    Beachwood, Ohio, 44122, United States

  • Innovaderm Research Inc.

    Montreal, H2K 4L5, Canada

  • Kenneth R. Beer MD

    West Palm Beach, Florida, 33401, United States

  • Olympian Clinical Research

    Tampa, Florida, 33609, United States

  • Premier Clinical Research

    Spokane, Washington, 99204, United States

  • Rivergate Dermatology Clinical Research Center, PLLC

    Goodlettsville, Tennessee, 37072, United States

  • Saint Louis University Dermatology

    St Louis, Missouri, 63122, United States

  • Shideler Clinical Research Center

    Carmel, Indiana, 46032, United States

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia, 23507, United States

  • Women's Clinical Research Center

    Seattle, Washington, 98105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.